OCT 19, 2019 8:59 AM PDT

An alternative for immunotherapy-resistant cancer patients

A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targeting tumors that more conventional immunotherapies might miss. The research comes from scientists at Yale and was published recently in a study in Nature Immunology.

While immunotherapies have greatly broadened treatment options for many cancer patients by enabling their immune systems to fight cancer on their own, immunotherapy also has its own downfalls. Immunotherapy doesn’t work for all cancers or all individual cancer patients, and in fact, a common form of immunotherapy called checkpoint inhibitors are only effective in about one-third of patients. This is why continued investigation around the human immune system and its connection to cancer is crucial.

The researchers from Yale have created a new system that combines viral gene therapy and CRISPR gene-editing technology. "This is an entirely new form of immunotherapy," said senior author Sidi Chen, who is an assistant professor of genetics. The system is called Multiplexed Activation of Endogenous Genes as Immunotherapy (MAEGI).

MAEGI works like a metal-detector for cancer cells, identifying their location and later tagging them for immune destruction. By doing so, the system is able to convert cold tumors to hot tumors (cold, meaning without immune cells, and hot meaning with immune cells). Additionally, explains Chen, "Once those cells are identified, the immune system immediately recognizes them if they show up in the future.” That allows for earlier future detection.

MAEGI offers hope for patients who do not respond to immunotherapies. Photo: Pixabay

The system was proven to work in mice with melanoma, triple-negative breast and pancreatic tumors. It was capable of either reducing or completely eradicating the tumors, no matter how close or far they were from the primary tumor.

The researchers hope that MAEGI will offer an alternative treatment option for those patients who are resistant to other immunotherapies. The team will be continuing their research to prepare for human clinical trials.

Sources: Yale, Science Daily

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
APR 29, 2020
Immunology
New Immune Cell Discovered in Mammary Ducts
APR 29, 2020
New Immune Cell Discovered in Mammary Ducts
Dubbed “ductal macrophages,” newly discovered immune cells found in breast tissue offer fresh promise for fu ...
MAY 01, 2020
Cancer
Cancer patients' high mortality from COVID-19
MAY 01, 2020
Cancer patients' high mortality from COVID-19
A study published today in the online edition of Cancer Discovery reports that people with cancer who develop COVID-19 a ...
MAY 25, 2020
Genetics & Genomics
FDA Approves the First Treatment for Neurofibromatosis 1
MAY 25, 2020
FDA Approves the First Treatment for Neurofibromatosis 1
In a major breakthrough, the Food and Drug Administration has approved a treatment for a genetic disorder called neurofi ...
JUN 04, 2020
Cancer
Inhibiting the Signals Critical for Cancer Growth in Merkel Cell Carcinoma
JUN 04, 2020
Inhibiting the Signals Critical for Cancer Growth in Merkel Cell Carcinoma
Merkel Cell Carcinoma (MCC) is a highly aggressive cancer of the skin. It is characterized by a high recurrence rate and ...
JUN 14, 2020
Cell & Molecular Biology
A Fungal Compound That Triggers Self-Destruction in Cancer Cells
JUN 14, 2020
A Fungal Compound That Triggers Self-Destruction in Cancer Cells
To describe it in a very basic way, cancer is uncontrolled cell growth. A number of processes regulate various aspects o ...
JUN 19, 2020
Cancer
Sedentary behavior associated with increased cancer mortality
JUN 19, 2020
Sedentary behavior associated with increased cancer mortality
A study published in JAMA Oncology reports findings that a greater amount of sedentary time was associated with a higher ...
Loading Comments...